{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:34:03Z","timestamp":1792704843419,"version":"4.5.0"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Prostate cancer (PCa) is characterized by high incidence and recurrence rates, presenting as an immune \u2018cold\u2019 tumor that exhibits a poor response to immunotherapy. The mechanisms underlying immune suppression and evasion within the tumor microenvironment (TME) of PCa remain inadequately understood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A comprehensive analysis of the immune environment in PCa was conducted using combined single-cell and spatial transcriptomic approaches, encompassing samples from healthy tissue, adjacent normal tissue, and localized tumors. Cell abundance and polarization state analyses were performed to identify pivotal cellular populations. Spatial deconvolution techniques were employed to elucidate cell composition within its spatial context. Additionally, cell niche and spatial colocalization analyses were conducted to evaluate potential cellular interactions. Immune response enrichment analysis was utilized to assess cellular response states. <jats:italic>In vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic> experiments were conducted to validate hypotheses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Data indicated a prevalent immunosuppressive state among CD8 T cells, accompanied by variations in cell abundance. Macrophages emerged as key regulators in recruiting CD8+ effector T cells and regulatory T cells (Tregs) into the TME, mediated by the CXCL12\/CXCR4 axis. A spatial proximity relationship was established between CD8+ effector T cells and Tregs, suggesting Tregs directly influence CD8+ T cell function. Immune cell state analysis revealed interleukin-2 (IL-2) as a critical cytokine in reshaping the immune microenvironment, with Tregs competitively depleting IL-2 and mediating IL-2\/STAT5 signaling to induce CD8+ effector T cell exhaustion. Treatment with CXCR4 inhibitor and IL-2 demonstrated significant antitumor effects and reversed immune dysfunction in both <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic> experiments, with combined treatment exhibiting superior efficacy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These findings elucidate the role of macrophages in mediating the CXCL12\/CXCR4 axis to aggregate CD8+ effector T cells and Tregs, thereby influencing the TME. Furthermore, Tregs competitively deplete IL-2 and mediate IL-2\/STAT5 signaling, leading to CD8+ effector T cells exhaustion and the establishment of an immunosuppressive microenvironment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1626708","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T05:28:56Z","timestamp":1751952536000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["CXCL12\/CXCR4 axis governs Treg spatial dominance over CD8+ T cells via IL-2 sequestration: a dual therapeutic target in prostate cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Junyi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HuiHui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-051517-011947","article-title":"Treatment of advanced prostate cancer","volume":"70","author":"Teo","year":"2019","journal-title":"Annu Rev Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"9511","DOI":"10.3390\/ijms21249511","article-title":"Gonadotropin-releasing hormone receptors in prostate cancer: molecular aspects and biological functions","volume":"21","author":"Fontana","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215619","article-title":"Molecular mechanisms and genetic alterations in prostate cancer: from diagnosis to targeted therapy","volume":"534","author":"Fontana","year":"2022","journal-title":"Cancer Lett"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00950-8","article-title":"Prostate cancer","volume":"398","author":"Sandhu","year":"2021","journal-title":"Lancet (London England)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-21-0121","article-title":"A subset of localized prostate cancer displays an immunogenic phenotype associated with losses of key tumor suppressor genes","volume":"27","author":"Calagua","year":"2021","journal-title":"Clin Cancer research: an Off J Am Assoc Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12943-024-02137-1","article-title":"Prostate cancer microenvironment: multidimensional regulation of immune cells, vascular system, stromal cells, and microbiota","volume":"23","author":"Chen","year":"2024","journal-title":"Mol Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s11658-023-00450-z","article-title":"Single-cell omics traces the heterogeneity of prostate cancer cells and the tumor microenvironment","volume":"28","author":"Yu","year":"2023","journal-title":"Cell Mol Biol Lett"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy-current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41467-023-36325-2","article-title":"Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses","volume":"14","author":"Hirz","year":"2023","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","article-title":"Doubletfinder: doublet detection in single-cell rna sequencing data using artificial nearest neighbors","volume":"8","author":"McGinnis","year":"2019","journal-title":"Cell Syst"},{"key":"B12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13059-020-1950-6","article-title":"Decontamination of ambient rna in single-cell rna-seq with decontx","volume":"21","author":"Yang","year":"2020","journal-title":"Genome Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0694-x","article-title":"Lineage tracking reveals dynamic relationships of T cells in colorectal cancer","volume":"564","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.cell.2021.01.053","article-title":"Covid-19 immune features revealed by a large-scale single-cell transcriptome atlas","volume":"184","author":"Ren","year":"2021","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-021-01033-z","article-title":"Differential abundance testing on single-cell data using K-nearest neighbor graphs","volume":"40","author":"Dann","year":"2022","journal-title":"Nat Biotechnol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0605-1","article-title":"Cell type prioritization in single-cell data","volume":"39","author":"Skinnider","year":"2021","journal-title":"Nat Biotechnol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00356-3","article-title":"Cell type and gene expression deconvolution with bayesprism enables bayesian integrative analysis across bulk and single-cell rna sequencing in oncology","volume":"3","author":"Chu","year":"2022","journal-title":"Nat Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-021-01139-4","article-title":"Cell2location maps fine-grained cell types in spatial transcriptomics","volume":"40","author":"Kleshchevnikov","year":"2022","journal-title":"Nat Biotechnol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13059-022-02663-5","article-title":"Explainable multiview framework for dissecting spatial relationships from highly multiplexed data","volume":"23","author":"Tanevski","year":"2022","journal-title":"Genome Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-024-01045-4","article-title":"Cellchat for systematic analysis of cell-cell communication from single-cell transcriptomics","volume":"20","author":"Jin","year":"2024","journal-title":"Nat Protoc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"7851","DOI":"10.1038\/s41467-022-35519-4","article-title":"A balanced measure shows superior performance of pseudobulk methods in single-cell rna-sequencing analysis","volume":"13","author":"Murphy","year":"2022","journal-title":"Nat Commun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06816-9","article-title":"Dictionary of immune responses to cytokines at single-cell resolution","volume":"625","author":"Cui","year":"2023","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-17-0530","article-title":"Amd3100 augments the efficacy of mesothelin-targeted, immune-activating vic-008 in mesothelioma by modulating intratumoral immunosuppression","volume":"6","author":"Li","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-0642-1","article-title":"Single-cell transcriptomics identifies a distinct luminal progenitor cell type in distal prostate invagination tips","volume":"52","author":"Guo","year":"2020","journal-title":"Nat Genet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0046-y","article-title":"Biology and regulation of il-2: from molecular mechanisms to human therapy","volume":"18","author":"Spolski","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.it.2023.09.003","article-title":"Il-2-driven cd8(+) T cell phenotypes: implications for immunotherapy","volume":"44","author":"Niederlova","year":"2023","journal-title":"Trends Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1172\/jci180080","article-title":"Spatial and functional targeting of intratumoral tregs reverses cd8+ T cell exhaustion and promotes cancer immunotherapy","volume":"134","author":"Zhou","year":"2024","journal-title":"J Clin Invest"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-021-00146-0","article-title":"From bulk, single-cell to spatial rna sequencing","volume":"13","author":"Li","year":"2021","journal-title":"Int J Oral Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduction Targeted Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu Rev Pathology: Mech Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","article-title":"Metabolism, metabolites, and macrophages in cancer","volume":"16","author":"Li","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J Cell Physiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Yunna","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-09-2329","article-title":"Cxcl12 (Sdf-1)\/cxcr4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin Cancer research: an Off J Am Assoc Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7371","DOI":"10.3390\/ijms22147371","article-title":"Cxcl12-cxcr4\/cxcr7 axis in colorectal cancer: therapeutic target in preclinical and clinical studies","volume":"22","author":"Khare","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.12.007","article-title":"The cxcl12-cxcr4\/cxcr7 axis as a mechanism of immune resistance in gastrointestinal Malignancies","volume":"65","author":"Daniel","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.82317","article-title":"Cxcl12-cxcr4\/cxcr7 axis in cancer: from mechanisms to clinical applications","volume":"19","author":"Yang","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12943-022-01597-7","article-title":"Comprehensive characterization of the prostate tumor microenvironment identifies cxcr4\/cxcl12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer","volume":"21","author":"Heidegger","year":"2022","journal-title":"Mol Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12943-016-0552-0","article-title":"Pharmacological targeting of cxcl12\/cxcr4 signaling in prostate cancer bone metastasis","volume":"15","author":"Conley-LaComb","year":"2016","journal-title":"Mol Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105010","article-title":"Cxcr4 antagonist amd3100 (Plerixafor): from an impurity to a therapeutic agent","volume":"159","author":"Wang","year":"2020","journal-title":"Pharmacol Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40164-016-0050-5","article-title":"Effectiveness of amd3100 in treatment of leukemia and solid tumors: from original discovery to use in current clinical practice","volume":"5","author":"Liu","year":"2015","journal-title":"Exp Hematol Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.844142","article-title":"Immunotherapy: reshape the tumor immune microenvironment","volume":"13","author":"Lv","year":"2022","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-021-01103-4","article-title":"Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response","volume":"14","author":"Fu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101199","article-title":"Prostate cancer immunotherapy: improving clinical outcomes with a multi-pronged approach","volume":"4","author":"Sridaran","year":"2023","journal-title":"Cell Rep Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/cmi.2017.107","article-title":"The unique structural and functional features of cxcl12","volume":"15","author":"Janssens","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.immuni.2023.06.003","article-title":"Cxcr3 Expression in Regulatory T cells Drives Interactions with Type I Dendritic Cells in Tumors to Restrict Cd8(+) T cell Antitumor Immunity","volume":"56","author":"Moreno Ayala","year":"2023","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2019.05.004","article-title":"Cooperation between constitutive and inducible chemokines enables T cell engraftment and immune attack in solid tumors","volume":"35","author":"Dangaj","year":"2019","journal-title":"Cancer Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1016\/j.cell.2021.07.015","article-title":"Cxcr6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment","volume":"184","author":"Di Pilato","year":"2021","journal-title":"Cell"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.09.010","article-title":"T cell receptor stimulation-induced epigenetic changes and foxp3 expression are independent and complementary events required for treg cell development","volume":"37","author":"Ohkura","year":"2012","journal-title":"Immunity"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/ni909","article-title":"An essential role for scurfin in cd4+Cd25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160062","article-title":"Ctla-4 control over foxp3+ Regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Sci (New York NY)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.014","article-title":"Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy","volume":"41","author":"Tay","year":"2023","journal-title":"Cancer Cell"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000764","article-title":"Tumors establish resistance to immunotherapy by regulating T(Reg) recruitment via ccr4","volume":"8","author":"Marshall","year":"2020","journal-title":"J immunotherapy Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Mct-17-0341","article-title":"Ccr5-dependent homing of T regulatory cells to the tumor microenvironment contributes to skin squamous cell carcinoma development","volume":"16","author":"de Oliveira","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.02.017","article-title":"Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces","volume":"28","author":"Rubtsov","year":"2008","journal-title":"Immunity"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-01036-7","article-title":"Intricacies of tgf-B Signaling in treg and th17 cell biology","volume":"20","author":"Wang","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191247","article-title":"Effects of interleukin-2 in immunostimulation and immunosuppression","volume":"217","author":"Pol","year":"2020","journal-title":"J Exp Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0769-3","article-title":"The pd-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of pd-1 blockade therapies","volume":"21","author":"Kumagai","year":"2020","journal-title":"Nat Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo5409","article-title":"Interleukin-2-based therapies in cancer","volume":"14","author":"Raeber","year":"2022","journal-title":"Sci Trans Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-23-1263","article-title":"Cd8-targeted il2 unleashes tumor-specific immunity in human cancer tissue by reviving the dysfunctional T-cell pool","volume":"14","author":"Kaptein","year":"2024","journal-title":"Cancer Discov"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-23-1266","article-title":"Il2 targeted to cd8+ T cells promotes robust effector T-cell responses and potent antitumor immunity","volume":"14","author":"Moynihan","year":"2024","journal-title":"Cancer Discov"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and function of interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-055756","article-title":"Nonredundant roles for stat5a\/B in directly regulating foxp3","volume":"109","author":"Yao","year":"2007","journal-title":"Blood"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03861-0","article-title":"An engineered il-2 partial agonist promotes cd8(+) T cell stemness","volume":"597","author":"Mo","year":"2021","journal-title":"Nature"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1626708\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T05:28:59Z","timestamp":1751952539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1626708\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":65,"alternative-id":["10.3389\/fimmu.2025.1626708"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1626708","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"article-number":"1626708"}}